| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 02/26/2003 | CN1102048C Anticancer detoxicating pill and its preparing process |
| 02/26/2003 | CN1102046C Oral antibacterial composition |
| 02/26/2003 | CN1102045C Novel compositions containing lipids and stabilizing agent |
| 02/26/2003 | CN1102044C Dragon's blood micro sponge agent and its preparing technology |
| 02/25/2003 | WO2002026233A1 Infusion of ciprofloxacin having reduced acid content and being stable in storage |
| 02/25/2003 | USRE38009 A nutritional supplement, comprising a 3R-3'R stereoisomer of zeaxanthin in a digestible capsule or tablet designed and sized for human ingestion, wherein the 3R-3'R stereoisomer of zeaxanthin constitutes at least about 90 percent of all |
| 02/25/2003 | US6525214 Contacting 2-(4-isobutylphenyl)propionic acid of high enantiomorph purity with sodium base; salt formation to form sodium ibuprofen; analgesics, antipyretics, antiinflammatory agents |
| 02/25/2003 | US6525192 Low-substituted hydroxypropyl cellulose and process for producing same |
| 02/25/2003 | US6525145 Releasing active materials upon degradation |
| 02/25/2003 | US6525102 Increasing storage stability of interleukin-2 by incorporating free base form arginine and succinic acid |
| 02/25/2003 | US6525100 Composition and method for treating peyronie's disease and related fibrotic tissue disorders |
| 02/25/2003 | US6525084 Granulating a mixture containing an active ingredient and a carrier in a high shear mixing means with temperature regulating means for keeping the temperature below about 40 degrees C. in the mixture during granulation |
| 02/25/2003 | US6525058 1-ethyl methylester 4-((3- (p-(carboxyamidino)phenyl) -2-oxo-5-oxazolidinyl)methyl)-1-piperazineacetate; Gantofiban; antagonistic action to Glycoprotein GPIIb/IIIa receptor; oily base; gantofiban citrate |
| 02/25/2003 | US6525057 Sustained release ranolazine formulations |
| 02/25/2003 | US6525030 Gene delivery to periosteal cells by microneedle injection |
| 02/25/2003 | US6525020 For drug delivery |
| 02/25/2003 | US6524855 Methods for inducing the differentiation of monocytes into functional dendritic cells |
| 02/25/2003 | US6524623 Therapeutic compositions and methods of use thereof |
| 02/25/2003 | US6524621 Core formulation |
| 02/25/2003 | US6524620 Diltiazem controlled release formulation and method of manufacture |
| 02/25/2003 | US6524619 Interdependent biofactors and biomolecules, such as minerals, vitamins and antioxidants and their clinically useful formulations for support of endothelial physiology of the inner ear |
| 02/25/2003 | US6524618 Metformin hydrochloride, polyethylene oxide, hydroxypropyl cellulose, hydroxyethyl cellulose, and ethyl cellulose all with specific particle sizes, density and viscosity, an insoluble filler, a glidant and a lubricant; antidiabetics |
| 02/25/2003 | US6524617 Vinyl alcohol-vinylpyrrolidone copolymer and microcrystalline silicified cellulose for fillers of pharmaceutical tablets; hardness at low compression force, and low friability, without icreasing size |
| 02/25/2003 | US6524615 Hard shell capsule and a formulation comprising water insoluble medicament, high melting fatty ester, low viscosity oil, cellulosic polymer, and nonionic surfactant |
| 02/25/2003 | US6524613 Hepatocellular chimeraplasty |
| 02/25/2003 | US6524612 Adhesive cooling composition and process for its preparation |
| 02/25/2003 | US6524611 The latter for stability in aqueous medium, for human consumption |
| 02/25/2003 | US6524608 Intravesical drug delivery system |
| 02/25/2003 | US6524607 Nontoxic, nonglucocorticoid, biocompatible, biodegradable, controlled release material |
| 02/25/2003 | US6524606 Bioerodible polyorthoesters containing amine groups |
| 02/25/2003 | US6524602 Polymer delivery system in treatments for parasitic skin diseases |
| 02/25/2003 | US6524596 Cosmetic composition containing an aqueous dispersion of insoluble polymer material particles, use and method |
| 02/25/2003 | US6524595 Dermopharmaceuticals. |
| 02/25/2003 | US6524593 N-acetyl aldosamines and related N-acetyl compounds, and their topical use |
| 02/25/2003 | US6524592 Oil in water emulsion of white mineral oil, mannitol oleate emulsifier with clostridium and possibly chorynebacterium antigens for prevention of clostridial diseases of sheep (and lambs) |
| 02/25/2003 | US6524576 Probiotic composition; veterinary feed additive; food additive; microorganisms dispenser; eliminating an oil pollution; restoring organic fumes degrading microorganism population in a biofilter |
| 02/25/2003 | US6524575 Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications |
| 02/25/2003 | US6524564 Hair treatment or skin cosmetic composition which comprises at least one water soluble or water dispersible polymer formed from urethane (methacrylate) containing siloxane groups, and at least one cosmetic auxiliary |
| 02/25/2003 | US6524557 Aerosol formulations of peptides and proteins |
| 02/25/2003 | US6524556 Tricyclic compound dispersed in liquefied hydrofluoroalkane propellant; medium-chain fatty acid triglyceride as dispersant |
| 02/25/2003 | US6524305 Less air is within |
| 02/25/2003 | CA2420556A1 Infusion of ciprofloxacin having reduced acid content and being stable on storage |
| 02/25/2003 | CA2171852C Budesonide pellets with a controlled release pattern and process for producing them |
| 02/25/2003 | CA2113080C Topical composition containing penciclovir |
| 02/25/2003 | CA2104868C Method and products for treating the eye |
| 02/25/2003 | CA2085525C Long lasting aqueous dispersions or suspensions of pressure-resistant gas-filled microvesicles and methods for the preparation thereof |
| 02/25/2003 | CA2044706C Crystallization method to improve crystal structure and size |
| 02/20/2003 | WO2003014316A2 Immunomodulatory compositions, formulations, and methods for use thereof |
| 02/20/2003 | WO2003014305A2 Eukaryotic cells and method for preserving cells |
| 02/20/2003 | WO2003014296A2 A group of novel anti-cancer compounds with specific structure |
| 02/20/2003 | WO2003014247A1 Pressure-sensitive adhesive for the skin and tapes or sheets for the skin made by using the same |
| 02/20/2003 | WO2003014145A2 Peptides that bind to atherosclerotic lesions |
| 02/20/2003 | WO2003014086A1 Process for the preparation of amorphous form of torsemide |
| 02/20/2003 | WO2003013683A1 Methods for micronization of hydrophobic drugs |
| 02/20/2003 | WO2003013633A1 Inhalation device with a pharmaceutical composition |
| 02/20/2003 | WO2003013613A1 Percutaneous absorption type medicinal preparation |
| 02/20/2003 | WO2003013612A1 Polysaccharide-containing compositions and use thereof |
| 02/20/2003 | WO2003013611A1 Percutaneous absorption preparations |
| 02/20/2003 | WO2003013610A2 Surfactant compounds and uses thereof |
| 02/20/2003 | WO2003013609A1 Sustained-release medicines |
| 02/20/2003 | WO2003013608A1 ORAL PHARMACEUTICAL COMPOSITION CONTAINING A COMBINAITION OF PPARα AND A HMG-COA REDUCTASE INHIBITOR |
| 02/20/2003 | WO2003013607A1 ORAL PHARMACEUTICAL COMPOSITION CONTAINING A COMBINATION OF FENOFIBRATE AND A HMG-CoA REDUCTASE INHIBITOR |
| 02/20/2003 | WO2003013589A1 Isulin-containing oral spray and the preparation method thereof |
| 02/20/2003 | WO2003013566A1 High molecular weight, lipophilic, orally ingestible bioactive agents in formulations having improved bioavailability |
| 02/20/2003 | WO2003013556A1 Medicinal compositions having effects of ameliorating eye diseases and holding eye functions |
| 02/20/2003 | WO2003013550A1 Micronutrient phosphates as dietary and health supplements |
| 02/20/2003 | WO2003013547A1 Pharmaceutical composition comprising salmeterol and budesonide for the treatment of respiratory disorders |
| 02/20/2003 | WO2003013538A1 Oral dosage form comprising a therapeutic agent and an adverse-effect agent |
| 02/20/2003 | WO2003013529A1 Paroxetine glycyrrhizinate |
| 02/20/2003 | WO2003013525A1 Opioid agonist formulations with releasable and sequestered antagonist |
| 02/20/2003 | WO2003013513A1 Stable emulsion composition |
| 02/20/2003 | WO2003013511A1 Integrin inhibitors for the treatment of eye diseases |
| 02/20/2003 | WO2003013501A1 Improved pharmaceutical composition containing a ppar alpha agent and a process for preparing it |
| 02/20/2003 | WO2003013500A1 Improved pharmaceutical composition containing a ppar alpha agent and a process for preparing it |
| 02/20/2003 | WO2003013489A1 Treatment of nail infections with no |
| 02/20/2003 | WO2003013483A1 Coated filter bag material for oral administration of medicament in liquid and methods of making same |
| 02/20/2003 | WO2003013482A1 Transdermal delivery of 5-ht3 antagonists |
| 02/20/2003 | WO2003013481A1 The process of manufacturing pharmaceutical composition with increased content of poorly soluble pharmaceutical ingredients |
| 02/20/2003 | WO2003013480A1 Improved enteric formulation of fluoxetin |
| 02/20/2003 | WO2003013479A1 Compositions and methods to prevent abuse of opioids |
| 02/20/2003 | WO2003013478A2 Method of encapsulating an active substance |
| 02/20/2003 | WO2003013477A1 Drug release system for controlled therapy |
| 02/20/2003 | WO2003013476A1 Compositions and methods to prevent abuse of opioids |
| 02/20/2003 | WO2003013475A1 Injectable foam and novel pharmaceutical applications thereof |
| 02/20/2003 | WO2003013474A1 Nanoparticulate formulations of fenofibrate |
| 02/20/2003 | WO2003013473A1 Stabilized oral suspension formulation |
| 02/20/2003 | WO2003013472A1 Aqueous dispersion comprising stable nanoparticles of a water-insoluble active and an excipient like middle chain triglycerides (mct) |
| 02/20/2003 | WO2003013471A2 Pharmaceutical enteric coated composition comprising chitosan |
| 02/20/2003 | WO2003013470A1 Composition comprising paroxetine and a pharmaceutically acceptable glycyrrhizinate salt |
| 02/20/2003 | WO2003013445A1 Nanocapsules containing a steroid for cosmetic compositions |
| 02/20/2003 | WO2003013441A2 Levothyroxine compositions and methods |
| 02/20/2003 | WO2003013440A2 Treatment and prevention of heat shock protein-associated diseases and conditions |
| 02/20/2003 | WO2003013434A2 Methods and compositions for treating diseases associated with excesses in ace |
| 02/20/2003 | WO2003013433A2 Sequestered antagonist formulations |
| 02/20/2003 | WO2003013428A2 Nutritional supplements and methods of using same |
| 02/20/2003 | WO2003013421A2 Pharmaceutical composition comprising a water/oil/water double microemulsion incorporated in a solid support |
| 02/20/2003 | WO2003013277A1 Chitosan-containing powder |
| 02/20/2003 | WO2003013245A1 Polyamines and analogs for protecting cells during cancer chemotherapy and radiotherapy |
| 02/20/2003 | WO2002098951A3 Lipid-polymer-conjugates |
| 02/20/2003 | WO2002098390A3 Delivery of aerosols containing small particles through an inhalation route |